United Therapeutics Corp (UTHR)
258.23
+3.21
(+1.26%)
USD |
NASDAQ |
May 02, 16:00
258.23
0.00 (0.00%)
After-Hours: 19:56
United Therapeutics Max Drawdown (5Y): 60.30% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 60.30% |
March 31, 2024 | 60.30% |
February 29, 2024 | 60.30% |
January 31, 2024 | 60.30% |
December 31, 2023 | 60.30% |
November 30, 2023 | 60.30% |
October 31, 2023 | 60.30% |
September 30, 2023 | 60.30% |
August 31, 2023 | 60.30% |
July 31, 2023 | 60.30% |
June 30, 2023 | 60.30% |
May 31, 2023 | 60.30% |
April 30, 2023 | 60.30% |
March 31, 2023 | 60.30% |
February 28, 2023 | 60.30% |
January 31, 2023 | 60.30% |
December 31, 2022 | 60.30% |
November 30, 2022 | 60.30% |
October 31, 2022 | 60.30% |
September 30, 2022 | 60.30% |
August 31, 2022 | 60.30% |
July 31, 2022 | 60.30% |
June 30, 2022 | 60.30% |
May 31, 2022 | 60.30% |
April 30, 2022 | 60.30% |
Date | Value |
---|---|
March 31, 2022 | 60.30% |
February 28, 2022 | 60.30% |
January 31, 2022 | 60.30% |
December 31, 2021 | 60.30% |
November 30, 2021 | 60.30% |
October 31, 2021 | 60.30% |
September 30, 2021 | 60.30% |
August 31, 2021 | 60.30% |
July 31, 2021 | 60.30% |
June 30, 2021 | 60.30% |
May 31, 2021 | 60.30% |
April 30, 2021 | 60.30% |
March 31, 2021 | 60.30% |
February 28, 2021 | 60.30% |
January 31, 2021 | 60.30% |
December 31, 2020 | 60.30% |
November 30, 2020 | 60.30% |
October 31, 2020 | 60.30% |
September 30, 2020 | 60.30% |
August 31, 2020 | 60.30% |
July 31, 2020 | 60.30% |
June 30, 2020 | 60.30% |
May 31, 2020 | 60.30% |
April 30, 2020 | 60.30% |
March 31, 2020 | 60.30% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
55.47%
Minimum
May 2019
60.30%
Maximum
Jul 2019
60.21%
Average
60.30%
Median
Jul 2019
Max Drawdown (5Y) Benchmarks
Liquidia Corp | 93.87% |
Esperion Therapeutics Inc | 99.01% |
Vertex Pharmaceuticals Inc | 41.60% |
Heron Therapeutics Inc | 98.09% |
Aldeyra Therapeutics Inc | 90.10% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | 9.914 |
Beta (5Y) | 0.5389 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 33.96% |
Historical Sharpe Ratio (5Y) | 0.4687 |
Historical Sortino (5Y) | 1.151 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 10.42% |